Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginNet MarginOperating MarginReturn on Sales

ProQR Therapeutics (PRQR) Return on Capital Employed (2021 - 2023)

Historic Return on Capital Employed for ProQR Therapeutics (PRQR) over the last 3 years, with Q4 2023 value amounting to 0.3%.

  • ProQR Therapeutics' Return on Capital Employed rose 2400.0% to 0.3% in Q4 2023 from the same period last year, while for Dec 2023 it was 0.3%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.27% for FY2024, which is 100.0% up from last year.
  • As of Q4 2023, ProQR Therapeutics' Return on Capital Employed stood at 0.3%, which was up 2400.0% from 0.31% recorded in Q3 2023.
  • ProQR Therapeutics' 5-year Return on Capital Employed high stood at 0.3% for Q4 2023, and its period low was 0.58% during Q3 2022.
  • Over the past 3 years, ProQR Therapeutics' median Return on Capital Employed value was 0.37% (recorded in 2023), while the average stood at 0.4%.
  • Per our database at Business Quant, ProQR Therapeutics' Return on Capital Employed tumbled by -2100bps in 2022 and then soared by 2700bps in 2023.
  • ProQR Therapeutics' Return on Capital Employed (Quarter) stood at 0.33% in 2021, then plummeted by -63bps to 0.54% in 2022, then soared by 44bps to 0.3% in 2023.
  • Its Return on Capital Employed stands at 0.3% for Q4 2023, versus 0.31% for Q3 2023 and 0.37% for Q2 2023.